Please login to the form below

Not currently logged in
Email:
Password:

Fetcroja

This page shows the latest Fetcroja news and features for those working in and with pharma, biotech and healthcare.

UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme

The antibiotic treats infections caused by aerobic Gram-negative bacteria. Shionogi’s novel antibiotic Fetcroja has been selected for inclusion in a pilot subscription reimbursement scheme, launched by the UK’s ... Fetcroja was launched in the UK in

Latest news

  • Shionogi’s novel antibiotic trial data published in The Lancet Shionogi’s novel antibiotic trial data published in The Lancet

    The second study, CREDIBLE-CR, evaluated Fetcroja as a treatment for a diverse range of serious Carbapenem-resistant (CR) infections. ... Fetcroja launched in the UK in September, launching as a treatment of infections caused by aerobic Gram-negative

  • Shionogi's Gram-negative antibiotic launches in the UK Shionogi's Gram-negative antibiotic launches in the UK

    Novel antibiotic is indicated for use against Gram-negative bacterial infections. Shionogi’s new antibiotic Fetcroja is now available for use in the UK for the treatment of infections caused by ... The launch of Shionogi's Fetcroja (cefiderocol) in the

  • Modest meeting sees only two drugs recommended by CHMP Modest meeting sees only two drugs recommended by CHMP

    The CHMP recommended a marketing authorisation of Japanese pharma company Shionogi’s antimicrobial drug Fetcroja (cefiderocol) for the treatment of infections caused by Gram-negative organisms in adults with limited treatment ... options. According to

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...